Leak: Avandia and the integrity of the peer review process.
Berger
Eric
E
D016265:Conflict of Interest; D004345:Drug Industry; D004992:Ethics, Medical; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D017712:Peer Review, Research / Q000941:ethics*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone